Filter by:

Reset Filter
  • Life Sciences
Showing 1 - 12 of 68
Event

Pharma Law USA

Benjamin Fuller of Cornerstone Research will discuss the 340B drug program at this conference hosted by Informa Connect in Boston.

Event

Hatching a Procompetitive Settlement

Celeste Saravia of Cornerstone Research will join attorneys and a regulator at this webinar hosted by the Section of Antitrust Law of the American Bar Association.

Case

Tevra Brands LLC v. Bayer Healthcare LLC

A jury awarded the defendant a complete victory at trial in this antitrust litigation involving allegations of anticompetitive exclusive dealing in the market for flea and tick medications.

Podcast/Video

Our Curious Amalgam: How Do We Measure Innovation?

In an American Bar Association podcast, Penka Kovacheva of Cornerstone Research discussed how M&A affects innovation in the pharmaceutical industry.

Article

The Impact of Pharmaceutical M&A on Innovation

The authors examine existing academic literature on the impact of pharmaceutical mergers and acquisitions and identify remaining gaps.

Event

ASHEcon 2024: The Annual Conference of the American Society of Health Economists

Cornerstone Research staff and affiliated experts will speak at this annual conference hosted by the American Society of Health Economics.

Event

2024 Antitrust in Healthcare

Anup Malani of the University of Chicago and James Lee of Cornerstone Research will discuss competition issues in healthcare and life sciences at this American Bar Association conference.

Article

Entrenching and Leveraging Market Dominance in the 2023 Merger Guidelines: Insights from Amgen/Horizon

Insights from Amgen/Horizon merger on leveraging market dominance via bundling under 2023 Merger Guidelines.

Article

How A 3-Firm ‘Joint Effort’ Beat A $3.6B Pharma Antitrust Suit

In this Law360 article, counsel discusses Celeste Saravia’s pivotal role as the economic expert in a pharmaceutical antitrust lawsuit.

Case

Ciccio et al. v. SmileDirectClub LLC et al.

Class certification was denied in this false advertising matter.

Press Release

Brussels Team Expands with Experienced Competition Hire

Dr. Norbert Maier joins Cornerstone Research, with deep antitrust law and competition expertise from the EU Commission DG COMP team.

Article

5 Questions with Sayeh Nikpay: The 340B Drug Pricing Program

Professor Sayeh Nikpay of the University of Minnesota discusses the role and implementation challenges of the 340B Drug Pricing Program.

How can we help you?

If you are looking for a publication not on our website, contact us.